-
Giorgio Raimondi, PhD
- Associate Scientific Director for Transplant Immunology, Vascularized Composite Allotransplantation (VCA) Research Laboratory
- Associate Professor of Plastic and Reconstructive Surgery
-
Byoung Chol Oh, PhD
- • Associate Scientific Director for Translational Research, Vascularized Composite Allotransplantation (VCA) Research Laboratory
- Assistant Professor of Plastic and Reconstructive Surgery
Meet Our Team
Browse the Vascularized Composite Allotransplantation Lab Team
Associate Scientific Directors
Principal Investigators
-
Damon Cooney, MD PhD
- Clinical Director, Face Transplant Program, Johns Hopkins Comprehensive Transplant Center
- Associate Professor of Plastic and Reconstructive Surgery
-
Sashank K. Reddy, MD PhD
- Associate Director, Johns Hopkins Institute for NanoBioTechnology (INBT)
- Associate Professor of Plastic and Reconstructive Surgery
-
Sami H. Tuffaha, MD
- Director, Peripheral Nerve Surgery
- Assistant Professor of Plastic and Reconstructive Surgery
Daniel Martinez
Biology Enthusiast, Army Veteran
Daniel is a dedicated professional with a Bachelor's degree in Science, specializing in Biology with a concentration in Molecular Biology. Combining a solid academic background with extensive practical experience, Daniel Martinez has excelled as a Researcher and Laboratory Manager, bringing leadership and expertise to scientific endeavors.
Having served in the military, Daniel brings a disciplined and strategic approach to all endeavors. With a passion for tackling complex challenges, Daniel has consulted for, conducted, managed and supervised research in various fields. Notably, he has contributed to studies on malaria in Southeast Asia and delved into the intricate world of the gut microbiome. Additionally, he has explored the complexities of Multiple Sclerosis and is currently delving in the field of Transplant Research, demonstrating a commitment to advancing knowledge in critical medical areas.
Beyond his scientific contributions, Daniel is deeply passionate about public health issues. He believes in leveraging his diverse range of experiences to address unique problems in research and beyond. His unwavering dedication to finding innovative solutions underscores his commitment to improving global health outcomes.
Daniel is committed to furthering his expertise and impact by pursuing a Master's in Public Health. By combining his background in biology with a focus on public health, he aims to make even greater strides in addressing pressing health challenges and advocating for improved health policies and practices.
In his pursuit of excellence, Daniel continues to blend academic rigor with real-world application, striving to make meaningful contributions to the scientific community and beyond.
Maria Shay, Sr. Research Administrative Coordinator
Joshua Bennett, Research Technologist
BS in Microbiology from BYU
Joshua worked in an immunology lab in undergrad for 3 years where he primarily studied novel cancer therapies, autoimmune therapies, and the effects of CD5. He is very interested in T cell related treatments and plans to go to grad school to study them.
Projects: CAR A2 and Type 1 Diabetes Projects.
Brendan Foley, M.S., Research Specialist
While getting his M.S. in Bioinformatics at Johns Hopkins, Brendan worked under the guidance of Dr. Raimondi, focusing on modifying thymic processes to improve VCA outcomes. After completing his Masters in 2023, Brendan continued his research on thymic modification as staff. Prior to school at Johns Hopkins, he earned dual bachelor's degrees in Information Systems Engineering as well as Applied Mathematics and Statistics at Stony Brook University. Outside of the lab, Brendan enjoys competing in volleyball, learning languages, and making music.
Eleni Drivas
Liang Zhou
Siavash Khaki
Heyyoung Kim, PhD
Immunogenicity in subzero stored VCA
Lotte van den Goor
Yi-nan Guo
Amanda Loftin
Ph.D. Candidate in Pathobiology, Johns Hopkins School of Medicine
Amanda “Mandy” Loftin is a veterinarian and translational scientist with 12+ years of research experience. Her Ph.D. thesis research focuses on one key question: How can we increase the availability of organs for transplant? To answer this question, Mandy uses nature-inspired methods and machine perfusion to develop new technologies for organ preservation, one of which was granted breakthrough device status by the FDA. Mandy is interested in developing animal models for human disease and draws from her extensive experience in various fields, including orthopedic surgery, cellular regeneration, immunopathology, and viral diseases. Her research has been recognized by several grants and awards from the National Institute of Diabetes and Digestive Kidney Diseases (NIDDK/NIH), the National Cancer Institute (NCI/NIH), and the American Society of Transplantation (AST). She is passionate about communicating science to diverse audiences and is a 2023 Empower Your Pitch competition winner.
Primary Project Title:
Extending Preservation of Kidneys for Transplant at Subzero Temperatures using Bioinspired Cryoprotectants
Alec Chen
Aaron Lewkowicz
PhD candidate
Accreditations: B.S. in Clinical Laboratory Science from Northern Michigan University
Aaron grew up amidst the HIV epidemic in South Africa which shaped their interest in developing affordable healthcare strategies, finding solutions to immune-mediated disease, and gaining a better understanding of resolution and the long-term consequences of inflammation. He has experience in urban and rural clinical labs in the USA, as well as overseas in India. While obtaining a B.S. in Clinical Laboratory Science, he trained is molecular assay development at Northern Michigan University. Additionally, he completed a fellowship in nephrology at the Mayo Clinic before becoming an ORISE fellow with the FDA in 2018. There he characterized the pathology of emerging diseases, including Zika and Ebola virus, to compare with intervention using antibody-based therapeutics. Presently, he is in Giorgio Raimondi’s laboratory exploring immune tolerance inducing therapies and novel inflammation sensitive drug delivery strategies with tissue and cell specificity.
Project: LiRiv – exploring T-cell modulating therapies to be incorporated with drug delivery strategies that enhance VCA engraftment.
Jessica Garvin
Yichuan Zhang
Yichuan loves travel and photography, and she also enjoys playing the piano in her spare time.